Patents by Inventor Keith Friend

Keith Friend has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device-based risk management of a therapeutic
    Patent number: 11830615
    Abstract: A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: November 28, 2023
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Frank S. Czerwiec, Amy Freedman, Keith Friend, Elaine A. O'Hara, Craig Ostroff, Marcelo De Freitas Santoro, Charles Shiner, Takeshi Watanabe, Miho Yamamoto, Christopher A. Zimmer
  • DEVICE-BASED RISK MANAGEMENT OF A THERAPEUTIC
    Publication number: 20190349375
    Abstract: A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 14, 2019
    Applicant: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Frank S. CZERWIEC, Amy FREEDMAN, Keith FRIEND, Elaine A. O'HARA, Craig OSTROFF, Marcelo DE FREITAS SANTORO, Charles SHINER, Takeshi WATANABE, Miho YAMAMOTO, Christopher A. ZIMMER
  • Device based risk management of a therapeutic
    Patent number: 10412089
    Abstract: A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.
    Type: Grant
    Filed: July 26, 2016
    Date of Patent: September 10, 2019
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Frank S. Czerwiec, Amy Freedman, Keith Friend, Elaine A. O'Hara, Craig Ostroff, Marcelo De Freitas Santoro, Charles Shiner, Takeshi Watanabe, Miho Yamamoto, Christopher A. Zimmer
  • DEVICE-BASED RISK MANAGEMENT OF A THERAPEUTIC
    Publication number: 20160335411
    Abstract: A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.
    Type: Application
    Filed: July 26, 2016
    Publication date: November 17, 2016
    Applicant: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Frank S. CZERWIEC, Amy FREEDMAN, Keith FRIEND, Elaine A. O'HARA, Craig OSTROFF, Marcelo DE FREITAS SANTORO, Charles SHINER, Takeshi WATANABE, Miho YAMAMOTO, Christopher A. ZIMMER
  • Therapeutical conversion
    Publication number: 20050153899
    Abstract: This invention provides a method of therapeutical conversion from a long-acting release (LAR) formulation of octreotide, e.g. Sandostatin® LAR®, to pegvisomant (Somavert®) for the acromegalic patients through a therapeutically overlapping transition period to a final dose range of pegvisomant established.
    Type: Application
    Filed: May 6, 2004
    Publication date: July 14, 2005
    Inventors: Pia Burman, Keith Friend
  • Methods and compositions for treating, preventing or delaying onset of a neoplasm
    Publication number: 20030212088
    Abstract: Methods of treating, preventing or delaying onset of a neoplasm comprise administering to an individual an anti-neoplastic agent and a growth hormone receptor antagonist. Methods for reducing tumor weight or volume comprise administering to an individual an anti-neoplastic agent and a growth hormone receptor antagonist. Compositions comprise an anti-neoplastic agent and a growth hormone receptor antagonist.
    Type: Application
    Filed: April 25, 2003
    Publication date: November 13, 2003
    Inventor: Keith Friend